Annual EBITDA:
-$111.56M-$43.73M(-64.46%)Summary
- As of today, ATXS annual EBITDA is -$111.56 million, with the most recent change of -$43.73 million (-64.46%) on December 31, 2024.
- During the last 3 years, ATXS annual EBITDA has fallen by -$81.20 million (-267.46%).
- ATXS annual EBITDA is now -626.95% below its all-time high of -$15.35 million, reached on December 1, 2012.
Performance
ATXS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$34.10M+$1.72M(+4.79%)Summary
- As of today, ATXS quarterly EBITDA is -$34.10 million, with the most recent change of +$1.72 million (+4.79%) on September 30, 2025.
- Over the past year, ATXS quarterly EBITDA has dropped by -$5.09 million (-17.54%).
- ATXS quarterly EBITDA is now -674.04% below its all-time high of -$4.41 million, reached on March 31, 2014.
Performance
ATXS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$136.51M-$5.09M(-3.87%)Summary
- As of today, ATXS TTM EBITDA is -$136.51 million, with the most recent change of -$5.09 million (-3.87%) on September 30, 2025.
- Over the past year, ATXS TTM EBITDA has dropped by -$35.54 million (-35.20%).
- ATXS TTM EBITDA is now -2998.28% below its all-time high of -$4.41 million, reached on March 31, 2014.
Performance
ATXS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ATXS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -64.5% | -17.5% | -35.2% |
| 3Y3 Years | -267.5% | -175.3% | -180.2% |
| 5Y5 Years | -312.2% | -213.9% | -675.3% |
ATXS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -267.5% | at low | -175.3% | +7.8% | -180.2% | at low |
| 5Y | 5-Year | -312.2% | at low | -523.1% | +7.8% | -675.3% | at low |
| All-Time | All-Time | -627.0% | at low | -674.0% | +7.8% | -2998.3% | at low |
ATXS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$34.10M(+4.8%) | -$136.51M(-3.9%) |
| Jun 2025 | - | -$35.82M(+3.2%) | -$131.42M(-5.6%) |
| Mar 2025 | - | -$36.99M(-25.0%) | -$124.40M(-11.5%) |
| Dec 2024 | -$111.56M(-64.5%) | -$29.59M(-2.0%) | -$111.56M(-10.5%) |
| Sep 2024 | - | -$29.01M(-0.7%) | -$100.97M(-9.5%) |
| Jun 2024 | - | -$28.80M(-19.3%) | -$92.19M(-17.5%) |
| Mar 2024 | - | -$24.15M(-27.1%) | -$78.49M(-15.7%) |
| Dec 2023 | -$67.83M(-26.8%) | -$19.00M(+6.1%) | -$67.83M(-7.5%) |
| Sep 2023 | - | -$20.24M(-34.0%) | -$63.12M(-14.2%) |
| Jun 2023 | - | -$15.10M(-11.9%) | -$55.27M(-7.1%) |
| Mar 2023 | - | -$13.49M(+5.6%) | -$51.62M(+3.5%) |
| Dec 2022 | -$53.50M(-76.2%) | -$14.29M(-15.4%) | -$53.50M(-9.8%) |
| Sep 2022 | - | -$12.39M(-8.2%) | -$48.72M(-10.1%) |
| Jun 2022 | - | -$11.45M(+25.5%) | -$44.23M(-9.8%) |
| Mar 2022 | - | -$15.38M(-61.7%) | -$40.27M(-32.6%) |
| Dec 2021 | -$30.36M(+18.9%) | -$9.51M(-20.4%) | -$30.36M(-1.8%) |
| Sep 2021 | - | -$7.90M(-5.5%) | -$29.84M(+9.0%) |
| Jun 2021 | - | -$7.49M(-36.8%) | -$32.80M(-29.6%) |
| Mar 2021 | - | -$5.47M(+39.0%) | -$25.31M(-27.6%) |
| Dec 2020 | -$37.44M(-38.3%) | -$8.98M(+17.4%) | -$19.84M(-12.7%) |
| Sep 2020 | - | -$10.86M(-61.1%) | -$17.61M(+34.9%) |
| Dec 2019 | -$27.06M | -$6.74M(-1.0%) | -$27.06M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$6.67M(+8.8%) | -$26.40M(-2.6%) |
| Jun 2019 | - | -$7.32M(-15.7%) | -$25.73M(-6.7%) |
| Mar 2019 | - | -$6.33M(-4.0%) | -$24.10M(+4.9%) |
| Dec 2018 | -$25.35M(+5.4%) | -$6.08M(-1.3%) | -$25.35M(-2.8%) |
| Sep 2018 | - | -$6.00M(-5.4%) | -$24.67M(+3.4%) |
| Jun 2018 | - | -$5.69M(+24.9%) | -$25.55M(+4.3%) |
| Mar 2018 | - | -$7.58M(-40.4%) | -$26.69M(+0.4%) |
| Dec 2017 | -$26.79M(+23.8%) | -$5.39M(+21.6%) | -$26.79M(+10.6%) |
| Sep 2017 | - | -$6.88M(-0.6%) | -$29.97M(+4.2%) |
| Jun 2017 | - | -$6.84M(+10.8%) | -$31.27M(+7.3%) |
| Mar 2017 | - | -$7.67M(+10.6%) | -$33.72M(+4.1%) |
| Dec 2016 | -$35.16M(-11.8%) | -$8.58M(-4.9%) | -$35.16M(-32.3%) |
| Sep 2016 | - | -$8.18M(+12.0%) | -$26.59M(-0.1%) |
| Jun 2016 | - | -$9.29M(-2.0%) | -$26.57M(-6.3%) |
| Mar 2016 | - | -$9.11M(-11.6%) | -$25.00M(-12.6%) |
| Dec 2015 | -$31.46M(-46.8%) | - | - |
| Sep 2015 | - | -$8.16M(-5.7%) | -$22.20M(-58.2%) |
| Jun 2015 | - | -$7.72M(-22.4%) | -$14.03M(-122.4%) |
| Mar 2015 | - | -$6.31M(-43.2%) | -$6.31M(-43.2%) |
| Dec 2014 | -$21.43M(-20.4%) | - | - |
| Mar 2014 | - | -$4.41M | -$4.41M |
| Dec 2013 | -$17.80M(-16.0%) | - | - |
| Dec 2012 | -$15.35M | - | - |
FAQ
- What is Astria Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Astria Therapeutics, Inc.?
- What is Astria Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Astria Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Astria Therapeutics, Inc.?
- What is Astria Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Astria Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Astria Therapeutics, Inc.?
- What is Astria Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Astria Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of ATXS is -$111.56M
What is the all-time high annual EBITDA for Astria Therapeutics, Inc.?
Astria Therapeutics, Inc. all-time high annual EBITDA is -$15.35M
What is Astria Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, ATXS annual EBITDA has changed by -$43.73M (-64.46%)
What is Astria Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ATXS is -$34.10M
What is the all-time high quarterly EBITDA for Astria Therapeutics, Inc.?
Astria Therapeutics, Inc. all-time high quarterly EBITDA is -$4.41M
What is Astria Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ATXS quarterly EBITDA has changed by -$5.09M (-17.54%)
What is Astria Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of ATXS is -$136.51M
What is the all-time high TTM EBITDA for Astria Therapeutics, Inc.?
Astria Therapeutics, Inc. all-time high TTM EBITDA is -$4.41M
What is Astria Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, ATXS TTM EBITDA has changed by -$35.54M (-35.20%)